Cargando…

Nuclear Factor kappa B is central to Marek’s Disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo

BACKGROUND: Marek’s Disease (MD) is a hyperproliferative, lymphomatous, neoplastic disease of chickens caused by the oncogenic Gallid herpesvirus type 2 (GaHV-2; MDV). Like several human lymphomas the neoplastic MD lymphoma cells overexpress the CD30 antigen (CD30(hi)) and are in minority, while the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Shyamesh, Kunec, Dusan, Buza, Joram J, Chiang, Hsin-I, Zhou, Huaijun, Subramaniam, Sugalesini, Pendarvis, Ken, Cheng, Hans H, Burgess, Shane C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472249/
https://www.ncbi.nlm.nih.gov/pubmed/22979947
http://dx.doi.org/10.1186/1752-0509-6-123
_version_ 1782246561501151232
author Kumar, Shyamesh
Kunec, Dusan
Buza, Joram J
Chiang, Hsin-I
Zhou, Huaijun
Subramaniam, Sugalesini
Pendarvis, Ken
Cheng, Hans H
Burgess, Shane C
author_facet Kumar, Shyamesh
Kunec, Dusan
Buza, Joram J
Chiang, Hsin-I
Zhou, Huaijun
Subramaniam, Sugalesini
Pendarvis, Ken
Cheng, Hans H
Burgess, Shane C
author_sort Kumar, Shyamesh
collection PubMed
description BACKGROUND: Marek’s Disease (MD) is a hyperproliferative, lymphomatous, neoplastic disease of chickens caused by the oncogenic Gallid herpesvirus type 2 (GaHV-2; MDV). Like several human lymphomas the neoplastic MD lymphoma cells overexpress the CD30 antigen (CD30(hi)) and are in minority, while the non-neoplastic cells (CD30(lo)) form the majority of population. MD is a unique natural in-vivo model of human CD30(hi) lymphomas with both natural CD30(hi) lymphomagenesis and spontaneous regression. The exact mechanism of neoplastic transformation from CD30(lo) expressing phenotype to CD30(hi) expressing neoplastic phenotype is unknown. Here, using microarray, proteomics and Systems Biology modeling; we compare the global gene expression of CD30(lo) and CD30(hi) cells to identify key pathways of neoplastic transformation. We propose and test a specific mechanism of neoplastic transformation, and genetic resistance, involving the MDV oncogene Meq, host gene products of the Nuclear Factor Kappa B (NF-κB) family and CD30; we also identify a novel Meq protein interactome. RESULTS: Our results show that a) CD30(lo) lymphocytes are pre-neoplastic precursors and not merely reactive lymphocytes; b) multiple transformation mechanisms exist and are potentially controlled by Meq; c) Meq can drive a feed-forward cycle that induces CD30 transcription, increases CD30 signaling which activates NF-κB, and, in turn, increases Meq transcription; d) Meq transcriptional repression or activation of the CD30 promoter generally correlates with polymorphisms in the CD30 promoter distinguishing MD-lymphoma resistant and susceptible chicken genotypes e) MDV oncoprotein Meq interacts with proteins involved in physiological processes central to lymphomagenesis. CONCLUSIONS: In the context of the MD lymphoma microenvironment (and potentially in other CD30(hi) lymphomas as well), our results show that the neoplastic transformation is a continuum and the non-neoplastic cells are actually pre-neoplastic precursor cells and not merely immune bystanders. We also show that NF-κB is a central player in MDV induced neoplastic transformation of CD30-expressing lymphocytes in vivo. Our results provide insights into molecular mechanisms of neoplastic transformation in MD specifically and also herpesvirus induced lymphoma in general.
format Online
Article
Text
id pubmed-3472249
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34722492012-10-17 Nuclear Factor kappa B is central to Marek’s Disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo Kumar, Shyamesh Kunec, Dusan Buza, Joram J Chiang, Hsin-I Zhou, Huaijun Subramaniam, Sugalesini Pendarvis, Ken Cheng, Hans H Burgess, Shane C BMC Syst Biol Research Article BACKGROUND: Marek’s Disease (MD) is a hyperproliferative, lymphomatous, neoplastic disease of chickens caused by the oncogenic Gallid herpesvirus type 2 (GaHV-2; MDV). Like several human lymphomas the neoplastic MD lymphoma cells overexpress the CD30 antigen (CD30(hi)) and are in minority, while the non-neoplastic cells (CD30(lo)) form the majority of population. MD is a unique natural in-vivo model of human CD30(hi) lymphomas with both natural CD30(hi) lymphomagenesis and spontaneous regression. The exact mechanism of neoplastic transformation from CD30(lo) expressing phenotype to CD30(hi) expressing neoplastic phenotype is unknown. Here, using microarray, proteomics and Systems Biology modeling; we compare the global gene expression of CD30(lo) and CD30(hi) cells to identify key pathways of neoplastic transformation. We propose and test a specific mechanism of neoplastic transformation, and genetic resistance, involving the MDV oncogene Meq, host gene products of the Nuclear Factor Kappa B (NF-κB) family and CD30; we also identify a novel Meq protein interactome. RESULTS: Our results show that a) CD30(lo) lymphocytes are pre-neoplastic precursors and not merely reactive lymphocytes; b) multiple transformation mechanisms exist and are potentially controlled by Meq; c) Meq can drive a feed-forward cycle that induces CD30 transcription, increases CD30 signaling which activates NF-κB, and, in turn, increases Meq transcription; d) Meq transcriptional repression or activation of the CD30 promoter generally correlates with polymorphisms in the CD30 promoter distinguishing MD-lymphoma resistant and susceptible chicken genotypes e) MDV oncoprotein Meq interacts with proteins involved in physiological processes central to lymphomagenesis. CONCLUSIONS: In the context of the MD lymphoma microenvironment (and potentially in other CD30(hi) lymphomas as well), our results show that the neoplastic transformation is a continuum and the non-neoplastic cells are actually pre-neoplastic precursor cells and not merely immune bystanders. We also show that NF-κB is a central player in MDV induced neoplastic transformation of CD30-expressing lymphocytes in vivo. Our results provide insights into molecular mechanisms of neoplastic transformation in MD specifically and also herpesvirus induced lymphoma in general. BioMed Central 2012-09-14 /pmc/articles/PMC3472249/ /pubmed/22979947 http://dx.doi.org/10.1186/1752-0509-6-123 Text en Copyright ©2012 Kumar et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kumar, Shyamesh
Kunec, Dusan
Buza, Joram J
Chiang, Hsin-I
Zhou, Huaijun
Subramaniam, Sugalesini
Pendarvis, Ken
Cheng, Hans H
Burgess, Shane C
Nuclear Factor kappa B is central to Marek’s Disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo
title Nuclear Factor kappa B is central to Marek’s Disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo
title_full Nuclear Factor kappa B is central to Marek’s Disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo
title_fullStr Nuclear Factor kappa B is central to Marek’s Disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo
title_full_unstemmed Nuclear Factor kappa B is central to Marek’s Disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo
title_short Nuclear Factor kappa B is central to Marek’s Disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo
title_sort nuclear factor kappa b is central to marek’s disease herpesvirus induced neoplastic transformation of cd30 expressing lymphocytes in-vivo
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472249/
https://www.ncbi.nlm.nih.gov/pubmed/22979947
http://dx.doi.org/10.1186/1752-0509-6-123
work_keys_str_mv AT kumarshyamesh nuclearfactorkappabiscentraltomareksdiseaseherpesvirusinducedneoplastictransformationofcd30expressinglymphocytesinvivo
AT kunecdusan nuclearfactorkappabiscentraltomareksdiseaseherpesvirusinducedneoplastictransformationofcd30expressinglymphocytesinvivo
AT buzajoramj nuclearfactorkappabiscentraltomareksdiseaseherpesvirusinducedneoplastictransformationofcd30expressinglymphocytesinvivo
AT chianghsini nuclearfactorkappabiscentraltomareksdiseaseherpesvirusinducedneoplastictransformationofcd30expressinglymphocytesinvivo
AT zhouhuaijun nuclearfactorkappabiscentraltomareksdiseaseherpesvirusinducedneoplastictransformationofcd30expressinglymphocytesinvivo
AT subramaniamsugalesini nuclearfactorkappabiscentraltomareksdiseaseherpesvirusinducedneoplastictransformationofcd30expressinglymphocytesinvivo
AT pendarvisken nuclearfactorkappabiscentraltomareksdiseaseherpesvirusinducedneoplastictransformationofcd30expressinglymphocytesinvivo
AT chenghansh nuclearfactorkappabiscentraltomareksdiseaseherpesvirusinducedneoplastictransformationofcd30expressinglymphocytesinvivo
AT burgessshanec nuclearfactorkappabiscentraltomareksdiseaseherpesvirusinducedneoplastictransformationofcd30expressinglymphocytesinvivo